Mirum Pharmaceuticals, Inc. (MIRM) Profit Margins
Over the twelve months to 2026-06-30, Mirum Pharmaceuticals, Inc. (MIRM) had gross margin 81.7%, operating margin -134.9%, net margin -139.2%, free cash flow margin -37.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MIRMMirum Pharmaceuticals, Inc.Follow MIRM — free
—
Price chart with a free account
- Market cap
- 5.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 23 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 74.8% | 75.8% | 80.8% | 81.7% | |
| Operating margin | -906.1% | -170.3% | -58.6% | -26.0% | -4.2% | -134.9% | |
| Net margin | -438.9% | -176.0% | -87.7% | -26.1% | -4.5% | -139.2% | |
| FCF margin | -693.8% | -156.3% | -38.1% | 2.8% | 10.5% | -37.0% |
USD billions · SEC XBRL
Mirum Pharmaceuticals, Inc. — questions
- What is Mirum Pharmaceuticals, Inc.'s gross margin?
- 81.7% over the twelve months to 2026-06-30.
- What is Mirum Pharmaceuticals, Inc.'s operating margin?
- -134.9% over the twelve months to 2026-06-30.
- What is Mirum Pharmaceuticals, Inc.'s net profit margin?
- -139.2% over the twelve months to 2026-06-30.
Every figure on this page comes from Mirum Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.